Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
View ORCID ProfileDaniel Spakowicz, View ORCID ProfileRebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen
doi: https://doi.org/10.1101/19006429
Daniel Spakowicz
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
2Department of Biomedical Informatics, Ohio State University, Columbus, OH, USA
Rebecca Hoyd
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Mitchell Muniak
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Marium Husain
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
James S. Bassett
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Lei Wang
2Department of Biomedical Informatics, Ohio State University, Columbus, OH, USA
Gabriel Tinoco
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Sandip H. Patel
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Jarred Burkart
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Abdul Miah
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Mingjia Li
3Division of Hospital Medicine, Department of Internal Medicine, The Ohio State University College of Medicine
Andrew Johns
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Madison Grogan
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
David P. Carbone
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Claire F. Verschraegen
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Kari L. Kendra
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Gregory A. Otterson
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Lang Li
2Department of Biomedical Informatics, Ohio State University, Columbus, OH, USA
Carolyn J. Presley
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Dwight H. Owen
1Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA
Data Availability
Scripts to reproduce all figures and analyses can be found at https://github.com/spakowiczlab/co-med-io.
Posted November 14, 2019.
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen
medRxiv 19006429; doi: https://doi.org/10.1101/19006429
Inferring the role of the microbiome on survival in patients treated with immune checkpoint inhibitors: causal modeling, timing, and classes of concomitant medications
Daniel Spakowicz, Rebecca Hoyd, Mitchell Muniak, Marium Husain, James S. Bassett, Lei Wang, Gabriel Tinoco, Sandip H. Patel, Jarred Burkart, Abdul Miah, Mingjia Li, Andrew Johns, Madison Grogan, David P. Carbone, Claire F. Verschraegen, Kari L. Kendra, Gregory A. Otterson, Lang Li, Carolyn J. Presley, Dwight H. Owen
medRxiv 19006429; doi: https://doi.org/10.1101/19006429
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)